Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug Survival Analysis Is Not a Good Method for Assessing the Safety or Effectiveness of Systemic Therapies in Psoriasis.

× No keyword cloud information.

5 in total

1. Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR.

Authors: Kayleigh J Mason; Jonathan N W N Barker; Catherine H Smith; Philip J Hampton; Mark Lunt; Kathleen McElhone; Richard B Warren; Zenas Z N Yiu; Christopher E M Griffiths; A David Burden
Journal: JAMA Dermatol Date: 2018-05-01 Impact factor: 10.282

2. Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.

Authors: Carlos Pelayo Hernández-Fernández; Gregorio Carretero; Raquel Rivera; Carlos Ferrándiz; Esteban Daudén; Pablo de Cueva; Isabel Belinchón; Francisco Javier Gómez-García; Enrique Herrera-Acosta; Diana P Ruiz-Genao; Marta Ferrán; Mercé Alsina; Ofelia Baniandrés-Rodríguez; José Luis Sánchez-Carazo; Rafael Botella-Estrada; Antonio Sahuquillo-Torralba; Lourdes Rodríguez; Jaime Vilar-Alejo; Carmen García-Donoso; José M Carrascosa; Mar Llamas-Velasco; Enrique Herrera-Ceballos; Jose Luis López-Estebaranz; Conrad Pujol-Marco; Miguel Angel Descalzo; Ignacio Garcia-Doval
Journal: Acta Derm Venereol Date: 2021-01-04 Impact factor: 3.875

3. Drug survival and reasons for drug discontinuation in palmoplantar pustulosis: a retrospective multicenter study.

Authors: Christian Kromer; Dagmar Wilsmann-Theis; Sascha Gerdes; Sandra Philipp; Marthe-Lisa Schaarschmidt; Astrid Schmieder; Mohammed Dakna; Tobias Arnold; Wiebke Katharina Peitsch; Rotraut Mössner
Journal: J Dtsch Dermatol Ges Date: 2019-04-17 Impact factor: 5.584

4. Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis: A Study From the British Association of Dermatologists Biologics and Immunomodulators Register.

Authors: Zenas Z N Yiu; Kayleigh J Mason; Philip J Hampton; Nick J Reynolds; Catherine H Smith; Mark Lunt; Christopher E M Griffiths; Richard B Warren
Journal: JAMA Dermatol Date: 2020-12-02 Impact factor: 10.282

5. Polymorphism in Gene for ABCC2 Transporter Predicts Methotrexate Drug Survival in Patients with Psoriasis.

Authors: Jasna Grželj; Maruška Marovt; Pij B Marko; Irena Mlinarič-Raščan; Tanja Gmeiner; Alenka Šmid
Journal: Medicina (Kaunas) Date: 2021-10-01 Impact factor: 2.430

5 in total